PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 17, 2026Clinical ophthalmology0 citationsOpen Access

Long-Term Outcomes of Combined Phacoemulsification and Non-Penetrating Deep Sclerectomy versus Standalone Non-Penetrating Deep Sclerectomy

KSKhaled SafadiGVGustavo Gutierrez VargasYCYaacov Cnaany

Key Points

  • This study aims to compare the efficacy and safety of combined phacoemulsification and non-penetrating deep sclerectomy versus standalone non-penetrating deep sclerectomy in glaucoma patients.
  • Retrospective cohort study of eyes undergoing NPDS with or without phacoemulsification between 2013 and 2018.
  • Follow-up period extended through 2023, assessing surgical success through IOP outcomes.
  • Group comparisons included Phaco-NPDS, NPDS-IOL, and NPDS-Phakic.
  • Qualified success rates were 78.1% (Phaco-NPDS), 79.0% (NPDS-IOL), and 83.4% (NPDS-Phakic) with no significant differences (p=0.46).
  • Complete success rates showed similar trends: 69.2% (Phaco-NPDS), 68.0% (NPDS-IOL), and 73.3% (NPDS-Phakic) with p=0.16.
  • Standalone NPDS led to better complete success in young phakic eyes without cataracts compared to Phaco-NPDS.

Abstract

Purpose: To compare the efficacy and safety of combined phacoemulsification and non-penetrating deep sclerectomy (Phaco-NPDS) with standalone NPDS in a large glaucoma cohort with long-term follow-up. Methods: This retrospective cohort study included eyes that underwent primary NPDS with or without phacoemulsification between 2013 and 2018, with follow-up through 2023. Eyes were grouped as Phaco-NPDS, NPDS-IOL, or NPDS-Phakic. Procedure selection reflected clinical decision-making (primarily lens status/cataract, age, and visual acuity). The primary outcome was surgical success. Success was defined as postoperative IOP 5– 21 mmHg with a ≥ 20% reduction from baseline at each follow-up. Complete success required no hypotensive medications, whereas qualified success was defined with or without hypotensive medications. Success was also assessed using stricter IOP upper limits (≤ 18, ≤ 15, and ≤ 12 mmHg). Secondary outcomes included visual acuity (VA), IOP, medication use, postoperative procedures, and complications. Results: A total of 276 eyes from 242 patients were included (mean age 71.7± 14.9 years; follow-up 4.25± 2.4 years). Qualified and complete success rates (IOP 5– 21 mmHg) were 78.1% and 69.2% in Phaco-NPDS, 79.0% and 68.0% in NPDS-IOL, and 83.4% and 73.3% in NPDS-Phakic, with no significant between-group differences (qualified p=0.46; complete p=0.16). Cox regression showed better complete, but not qualified, success in young phakic eyes without cataract undergoing standalone NPDS compared with Phaco-NPDS. Postoperative mean VA, IOP, and medication use were similar across groups. GPT and needling were more common during the first postoperative year, particularly in the NPDS-IOL group (OR=1.55 and 1.70, respectively). Post-GPT iris incarceration was the most frequent complication (10.5%). Conclusion: Combining phacoemulsification with NPDS was not associated with reduced surgical success. Phaco-NPDS should be considered for patients with coexisting cataract and uncontrolled glaucoma when surgical intervention is indicated. In young phakic eyes without cataract, standalone NPDS may be considered to achieve higher complete success at stricter IOP targets. Keywords: glaucoma, non-penetrating deep sclerectomy, intra-ocular pressure, cataract, phacoemulsification

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Safadi et al. (2026) studied this question.

synapsesocial.com/papers/6a095bba7880e6d24efe196fhttps://doi.org/10.2147/opth.s579848
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery2001 · 1,188 citations
  2. 2Combined cataract and glaucoma surgery2001 · 18 citations
  3. 3Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 20402014 · 7,171 citations
  4. 4Needling revision with marking maneuver to locate the scleral flap2020 · 2 citations
  5. 5Nonpenetrating Deep Sclerectomy for Progressive Glaucoma: Long-term (5-year) Follow-up of Intraocular Pressure Control and Visual Field Survival2020 · 14 citations